DeepMed Research

Chinese Academy of Medical Sciences Peking Union Medical College Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Phase 1

Conditions: Multiple Myeloma

Interventions: Drug: C-CAR088

First Posted Date: 2020-03-04

Last Posted Date: 2020-03-04

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 10

Registration Number: NCT04295018

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents

Phase 4

Conditions: Type2 Diabetes Mellitus

Interventions: Drug: Glucophage 500Mg Tablet
Drug: Acarbose Tablets
Drug: Sitagliptin tablet
Drug: Dapagliflozin Tablet
Drug: Pioglitazone Tablets
Drug: Glimepiride Tablets

First Posted Date: 2020-02-27

Last Posted Date: 2020-02-27

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 180

Registration Number: NCT04287387

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders

Phase 1

Conditions: Lymphatic Disorders

Interventions: Drug: 68Ga-NEB

First Posted Date: 2020-02-18

Last Posted Date: 2020-02-18

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 90

Registration Number: NCT04273334

Locations: 🇨🇳
Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, Beijing, China

99mTc-HPArk2 SPECT/CT for the Detection of HER2-positive Breast Cancer

Early Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: 99mTc-HPArk2

First Posted Date: 2020-02-13

Last Posted Date: 2022-09-14

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 34

Registration Number: NCT04267900

Locations: 🇨🇳
Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, Beijing, China

The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia

Phase 2

Conditions: 2019-nCoV

Interventions: Other: Standard care
Drug: Intravenous Immunoglobulin

First Posted Date: 2020-02-07

Last Posted Date: 2020-02-07

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 80

Registration Number: NCT04261426

Effect of Pneumoperitoneum and Neuromuscular Block on Renal Function in Diabetes Patients

Not Applicable

Conditions: Diabetes Mellitus
Neuromuscular Blockade
Acute Kidney Injury
Laparoscopic Surgical Procedure

Interventions: Procedure: high pressure
Drug: deep neuromuscular block
Drug: moderate neuromuscular block
Procedure: low pressure

First Posted Date: 2020-02-06

Last Posted Date: 2020-10-06

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 648

Registration Number: NCT04259112

Effects of High-Flow Nasal Cannula Therapy Assessed by Electrical Impedance Tomography

Completed

Conditions: High-flow Nasal Cannula
Electrical Impedance Tomography

First Posted Date: 2020-01-28

Last Posted Date: 2020-01-28

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 24

Registration Number: NCT04245241

Locations: 🇨🇳
Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences,, Beijing, Beijing, China

Reference Intervals of the sEMG of the Pelvic Floor in Healthy Female

Conditions: Pelvic Floor

First Posted Date: 2020-01-28

Last Posted Date: 2020-01-28

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 1000

Registration Number: NCT04245137

Locations: 🇨🇳
Maternal and Child Health Hospital of Anhui Province, Hefei, Anhui, China
🇨🇳
Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, Beijing, China
🇨🇳
Gansu Province Maternal and Child Care Hospital, Lanzhou, Gansu, China

and more 4 locations

The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas

Phase 2

Conditions: Pituitary Adenomas

Interventions: Other: Radiotherapy plus placebo
Drug: Radiotherapy plus temozolomide

First Posted Date: 2020-01-28

Last Posted Date: 2020-01-28

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 150

Registration Number: NCT04244708

Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure

Phase 2

Completed

Conditions: COVID-19 Infections

Interventions: Other: Standard care
Drug: methylprednisolone therapy

First Posted Date: 2020-01-28

Last Posted Date: 2020-06-16

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 80

Registration Number: NCT04244591

Locations: 🇨🇳
Medical ICU,Peking Union Medical College Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy